Ventum Cap Mkts upgraded shares of MariMed (OTCMKTS:MRMD – Free Report) to a strong-buy rating in a report released on Thursday, Zacks.com reports.
MariMed Stock Performance
Shares of MariMed stock remained flat at $0.18 on Thursday. The stock had a trading volume of 220,343 shares, compared to its average volume of 437,308. The company has a fifty day moving average of $0.18 and a 200 day moving average of $0.24. MariMed has a one year low of $0.14 and a one year high of $0.55. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $67.90 million, a price-to-earnings ratio of -4.47 and a beta of 2.80.
About MariMed
Recommended Stories
- Five stocks we like better than MariMed
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 8/5 – 8/9
- Stock Dividend Cuts Happen Are You Ready?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- How to buy stock: A step-by-step guide for beginners
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.